Next-Generation-Sequencing Approach to Neutropenic Sepsis

NCT05815628 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-08-08

No results posted yet for this study

Summary

The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER in neutropenic patients with FN is to provide further evidence of the efficacy of an NGS-based approach for detecting bloodstream infection in neutropenic patients.

Conditions

Interventions

DIAGNOSTIC_TEST

DISQVER

NGS based infection diagnosis

Sponsors & Collaborators

  • Noscendo GmbH

    collaborator UNKNOWN
  • Boris Böll

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-05
Primary Completion
2026-09-30
Completion
2026-11-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05815628 on ClinicalTrials.gov